Blackberry Thumb and Stem Cells

By /
Medical illustration of the bones of human hand and wrist

Kate Aedon/Shutterstock

The CMC (Carpal Metacarpal) joint is at the base of the thumb. It’s the most common site of thumb arthritis.  Patients with this problem have difficulty lifting or grasping things and will often get knife like pain at this location where the thumb meets the wrist.  Options for these patients at this point are pretty limited and include steroid shots, joint replacement (not quite there yet), and removal of a wrist bone with replacement of the joint by a coiled up tendon.  While many of the joints we’ve treated with the patient’s own cultured stem cells are large joints, we have always liked treating smaller joints in the hand, foot, or spine, since they require relatively few cells to treat.  I had our research assistant yesterday pull our data on the patients we have treated over the past 2 years with CMC thumb arthritis to get a sense of how we’re doing with this type of hand arthritis.  The results?  We have treated 6 patients who are on average just under a year out (11.3 months) from treatment (this is far fewer than the several hundred large joints we have treated) with Regenexx-C.  83.4% of thumb patients are reporting greater than 50% improvement after a simple injection of their own stem cells, 66.7% of thumb patients are reporting greater than 75% improvement and the average change is 70% improved.  We have had no significant complications in this group.  A case report of a patient in this group of patients with thumb arthritis can be found here. This fits with my recollection of these patients.  Even if the effect only lasts 1-2 years (given our knee data I’d bet it lasts more than 2 years), this is such a small joint that most patients can grow enough cells for many, many treatments which can be saved “on ice” in cryo-preservation indefinitely.

Learn about Regenexx procedures for hand & wrist conditions.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get Blog Updates by Email

We do not sell, or share your information to third party vendors.

By submitting the form you agree that you’ve read and consent to our Privacy Policy. We may use email, phone, or other electronic means to communicate information about Regenexx.

We will provide information to help you decide whether you want to schedule an evaluation with a Regenexx Physician.

Insurance typically covers evaluations and diagnostic testing (if recommended). Most insurance plans currently do not cover Regenexx Procedures.

Copyright © Regenexx 2021. All rights reserved.



9035 Wadsworth Pkwy #1000
Westminster, CO 80021


*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.